Sclerotherapy vs no intervention
Serious adverse events and liver‐related morbidity: incidence of bleeding from gastric varices · primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis
It is very uncertain whether sclerotherapy changes serious adverse events and liver‐related morbidity: incidence of… compared with no intervention (very low certainty).
1 finding from 1 review
- Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with… 2020 · Cochrane Headline outcomes onlyRR 6.51 [0.34, 123.06]1 study · 108 participantsVery low